NCT00490230

Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application

Assessment of Cutaneous Leishmaniasis Scar (Caused by Leishmania Major) for Cosmetic Outcome After Treatment With WR279396 (Paromomycin/Gentamicin Cream in Vehicle) Versus a No Treatment Control Group (Natural Healing)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 108 (actual)
• Sponsor: U.S. Army Medical Research and Development Command · Federal
• Sex: All
• Age: 5 Years – 75 Years
• Healthy volunteers: Accepted

Summary

Primary Objectives: Assess whether CL (caused by Leishmaniasis major) lesions treated with WR279396 improved the cosmetic outcome compared with no treatment (natural healing)

Detailed description

Secondary Objectives 1. Evaluate the cosmetic outcome of CL lesions treated with "vehicle" compared with no treatment (natural healing) 2. Evaluate the cosmetic outcome of CL lesions treated with "vehicle" compared with WR279396 * To determine whether CL lesions treated with vehicle improves the cosmetic outcome (compared with natural healing) * To determine whether CL lesions treated with vehicle alone provides a cosmetic outcome similar to WR279396

Conditions

• Cutaneous Leishmaniasis
• Scar

Interventions

Type	Name	Description
DRUG	WR 279396

Timeline

• Start date: 2007-04-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2007-06-22
• Last updated: 2016-01-01

Locations

1 site across 1 country: Tunisia